AtriCure Inc (NAS:ATRC)
$ 23.76 2.565 (12.1%) Market Cap: 1.15 Bil Enterprise Value: 1.12 Bil PE Ratio: 0 PB Ratio: 2.52 GF Score: 72/100

AtriCure Inc at Needham Healthcare Conference Transcript

Apr 10, 2019 / 07:30PM GMT
Release Date Price: $27.39 (+2.01%)
Editor

Audio in progress.

Mike Matson
Needham & Company - Analyst

Medical device analyst here at Needham and Company. I have got AtriCure on stage with me: Mike Carrel, who is the CEO, to my left, and to his left is Andy Wade, CFO. So we are going to do another fireside chat. I will just start with the questions, kind of broken out by business revenue category here.

So I want to start with the open heart ablation category. So the Society guidelines were changed in early 2017. It's been almost I guess over two years now. So looking back, what do you think the impact has been? And it seems like it's provided a bit of a tailwind and do you think that will continue?

Mike Carrel
AtriCure, Inc. - President and CEO

Well, first, thanks for having us here and for the coverage that you have given. Really appreciate it, and appreciate the day that we have had here. So it has been a great conference so far for us.

The open business and the guidelines, the guidelines have been incredibly helpful because they

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot